Literature DB >> 6432360

Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats.

H A Kontos, E P Wei, J T Povlishock, C W Christman.   

Abstract

Topical application of sodium arachidonate (50-200 micrograms/ml) or bradykinin (0.1-10 micrograms/ml) on the brain surface of anesthetized cats caused dose-dependent cerebral arteriolar dilation. This dilation was blocked by 67-100% in the presence of superoxide dismutase and catalase. These enzymes did not affect the changes in arteriolar diameter caused by alterations in arterial blood PCO2, or the arteriolar dilation from topical acetylcholine. Enzymes inactivated by heat had no effect on the vasodilation from arachidonate or bradykinin. Superoxide dismutase alone or catalase alone reduced the dilation during application of 200 micrograms/ml of arachidonate for 15 minutes; they also completely prevented the residual dilation seen 1 hour after washout, as well as the reduction in the vasoconstrictive effects of arterial hypocapnia observed at this time. The results show that superoxide anion radical and hydrogen peroxide, or radicals derived from them, such as the hydroxyl radical, are mediators of the cerebral arteriolar dilation from sodium arachidonate or bradykinin. These radicals are not the endothelium-derived relaxant factor released by acetylcholine. The presence of both superoxide anion radical and hydrogen peroxide is required for the production of the vascular damage seen during prolonged application of high concentrations of sodium arachidonate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432360     DOI: 10.1161/01.res.55.3.295

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  20 in total

1.  Acute effects of bradykinin on cerebral microvascular permeability in the anaesthetized rat.

Authors:  M H Sarker; D E Hu; P A Fraser
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

2.  Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney.

Authors:  D Fulton; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

Review 3.  The roles of free radicals in amyotrophic lateral sclerosis.

Authors:  D Liu
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

4.  The role of bradykinin in the etiology of vasogenic brain edema and perilesional brain dysfunction.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

5.  Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone.

Authors:  L Schürer; P Temesvari; M Wahl; A Unterberg; A Baethmann
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery.

Authors:  Anthie Ellis; Malarvannan Pannirselvam; Todd J Anderson; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

Review 7.  Posthypothermic rewarming considerations following traumatic brain injury.

Authors:  John T Povlishock; Enoch P Wei
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

8.  Lipid peroxidation in experimental spinal cord injury: time-level relationship.

Authors:  S Barut; A Canbolat; T Bilge; Y Aydin; B Cokneşeli; U Kaya
Journal:  Neurosurg Rev       Date:  1993       Impact factor: 3.042

9.  Role of hydrogen peroxide and the impact of glutathione peroxidase-1 in regulation of cerebral vascular tone.

Authors:  Mary L Modrick; Sean P Didion; Cynthia M Lynch; Sanjana Dayal; Steven R Lentz; Frank M Faraci
Journal:  J Cereb Blood Flow Metab       Date:  2009-04-08       Impact factor: 6.200

10.  Cytochrome P450-dependent effects of bradykinin in the rat heart.

Authors:  D Fulton; K Mahboubi; J C McGiff; J Quilley
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.